Cancer before and after the start of hemodialysis and association with mortality – an Eastern-European multicenter study

References

• Rosales BM, De La Mata N, Vajdic CM, et al. Cancer mortality in people receiving dialysis for kidney failure: an Australian and New Zealand cohort study, 1980–2013. Am J Kidney Dis. 2022;80(4):1–9. doi: 10.1053/j.ajkd.2022.03.010.
   PubMed Web of Science ®Google Scholar
• Taborelli M, Toffolutti F, Del Zotto S, et al. Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy. BMC Nephrol. 2019;20(1):107. doi: 10.1186/s12882-019-1283-4.
   PubMedGoogle Scholar
• Cheung CY, Tang SCW. Oncology in nephrology comes of age: a focus on chronic dialysis patients. Nephrology. 2019;24(4):380–386. doi: 10.1111/nep.13525.
   PubMed Web of Science ®Google Scholar
• Xie X, Li F, Xie L, et al. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis. Open Life Sci. 2023; 18(1):20220553. doi: 10.1515/biol-2022-0553.
   PubMed Web of Science ®Google Scholar
• Hu M, Wang Q, Liu B, et al. Chronic kidney disease and cancer: inter-Relationships and mechanisms. Front Cell Dev Biol. 2022;10:868715. doi: 10.3389/fcell.2022.868715.
   PubMed Web of Science ®Google Scholar
• Stewart JH, Vajdic CM, van Leeuwen MT, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009;24(10):3225–3231. doi: 10.1093/ndt/gfp331.
   PubMed Web of Science ®Google Scholar
• Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018;33(suppl_3):iii35–iii40. doi: 10.1093/ndt/gfy175.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Lee E, Park B, et al. Epidemiological characteristics of cancers in patients with end-stage kidney disease: a Korean nationwide study. Sci Rep. 2021;11(1):3929. doi: 10.1038/s41598-021-83164-6.
   PubMed Web of Science ®Google Scholar
• Myung J, Choi JH, Yi JH, et al. Cancer incidence according to the national health information database in Korean patients with end-stage renal disease receiving hemodialysis. Korean J Intern Med. 2020;35(5):1210–1219. doi: 10.3904/kjim.2018.400.
   PubMed Web of Science ®Google Scholar
• Butler AM, Olshan AF, Kshirsagar AV, et al. Cancer incidence among US medicare ESRD patients receiving hemodialysis, 1996-2009. Am J Kidney Dis. 2015;65(5):763–772. doi: 10.1053/j.ajkd.2014.12.013.
   PubMed Web of Science ®Google Scholar
• Hortlund M, Mühr LSA, Storm H, et al. Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer. 2017;140(5):1091–1101. doi: 10.1002/ijc.30531.
   PubMed Web of Science ®Google Scholar
• Béchade C, Dejardin O, Bara S, et al. Survival of patients with cancer starting chronic dialysis: data from kidney and cancer registries in lower normandy. Nephrology. 2018;23(12):1125–1130. doi: 10.1111/nep.13091.
   PubMed Web of Science ®Google Scholar
• Stel VS, de Jong RW, Kramer A, et al. Supplemented ERA-EDTA registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in Europe. Kidney Int. 2021;100(1):182–195. doi: 10.1016/j.kint.2020.12.010.
   PubMed Web of Science ®Google Scholar
• Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol. 2010;23:253–262.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279–335.
   Web of Science ®Google Scholar
• Kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1–59.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International classification of diseases for oncology (ICD-O)., 3rd edition, 1st revision. Geneva: World Health Organization, 2013.
   Google Scholar
• Available from: https://www.registrulrenal.ro/resurse_statistica/Raport_RRR_2020_covid.pdf.
   Google Scholar
• Sever MŞ, Jager KJ, Vanholder R, et al. A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community. Clin Kidney J. 2020;14(1):23–35. doi: 10.1093/ckj/sfaa218.
   PubMed Web of Science ®Google Scholar
• Spasovski G, Rroji M, Vazelov E, et al. Nephrology in the Eastern and Central European region: challenges and opportunities. Kidney Int. 2019;96(2):287–290. doi: 10.1016/j.kint.2019.02.040.
   PubMed Web of Science ®Google Scholar
• Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354(9173):93–99. doi: 10.1016/s0140-6736(99)06154-1.
   PubMed Web of Science ®Google Scholar
• Available from: https://gco.iarc.fr/today/data/factsheets/populations/642-romania-fact-sheets.pdf.
   Google Scholar
• Lee JE, Han SH, Cho BC, et al. Cancer in patients on chronic dialysis in Korea. J Korean Med Sci. 2009;24 (Suppl 1):S95–S101. doi: 10.3346/jkms.2009.24.S1.S95.
   PubMedGoogle Scholar
• Chien CC, Han MM, Chiu YH, et al. Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer. 2017;8(1):9–18. doi: 10.7150/jca.16550.
   PubMed Web of Science ®Google Scholar
• Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol. 2009;20(6):1341–1350. doi: 10.1681/ASN.2008090998.
   PubMed Web of Science ®Google Scholar
• Iff S, Craig JC, Turner R, et al. Reduced estimated GFR and cancer mortality. Am J Kidney Dis. 2014;63(1):23–30. doi: 10.1053/j.ajkd.2013.07.008.
   PubMed Web of Science ®Google Scholar
• Mok Y, Ballew SH, Sang Y, et al. Albuminuria, kidney function, and cancer risk in the community. Am J Epidemiol. 2020;189(9):942–950. doi: 10.1093/aje/kwaa043.
   PubMed Web of Science ®Google Scholar
• Wong G, Staplin N, Emberson J, et al. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer. 2016;16:488. doi: 10.1186/s12885-016-2532-6.
   PubMed Web of Science ®Google Scholar
• Morel A, Meuleman MS, Moktefi A, et al. Renal diseases associated with hematologic malignancies and thymoma in the absence of renal monoclonal immunoglobulin deposits. Diagnostics. 2021;11(4):710. doi: 10.3390/diagnostics11040710.
   Web of Science ®Google Scholar
• Varga A, Tilea I, Petra DN, et al. Cardiovascular events throughout the disease course in chronic myeloid leukaemia patients treated with tyrosine kinase Inhibitors – a single-centre retrospective study. JCM. 2020;9(10):3269. doi: 10.3390/jcm9103269.
   Google Scholar
• Oh HJ, Lee HA, Moon CM, et al. Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: a nationwide population-based cohort study. PLoS One. 2018;13(11):e0207756. doi: 10.1371/journal.pone.0207756.
   PubMed Web of Science ®Google Scholar
• Capasso A, Benigni A, Capitanio U, et al. Summary of the international conference on Onco-Nephrology: an emerging field in medicine. Kidney Int. 2019;96(3):555–567. doi: 10.1016/j.kint.2019.04.043.
   PubMed Web of Science ®Google Scholar
• Małyszko J, Kozlowski L, Kozłowska K, et al. Cancer and the kidney: dangerous liaisons or price paid for the progress in medicine? Oncotarget. 2017;8(39):66601–66619. doi: 10.18632/oncotarget.18094.
   PubMedGoogle Scholar
• Zinger A, Cho WC, Ben-Yehuda A. Cancer and aging – the inflammatory connection. Aging Dis. 2017;8(5):611–627. doi: 10.14336/AD.2016.1230.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63(3):793–808. doi: 10.1046/j.1523-1755.2003.00803.x.
   PubMed Web of Science ®Google Scholar
• Lornoy W, Becaus S, de Vleeschouwer M, et al. Renal cell carcinoma, a new complication of analgesic nephropathy. Lancet. 1986;1(8492):1271–1272. doi: 10.1016/s0140-6736(86)91407-8.
   PubMed Web of Science ®Google Scholar
• Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342(23):1686–1692. doi: 10.1056/NEJM200006083422301.
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Polenakovic M, Toncheva D. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease. Pathol Biol. 2011;59(5):286–291. doi: 10.1016/j.patbio.2009.05.002.
   PubMedGoogle Scholar
• Lin MY, Kuo MC, Hung CC, et al. Association of dialysis with the risks of cancers. PLoS One. 2015;10(4):e0122856. doi: 10.1371/journal.pone.0122856.
   PubMed Web of Science ®Google Scholar
• Gomotirceanu AM, Sabău A, Gomotîrceanu F, et al. CEUS utility in the diagnosis of a stage I renal cancer developed on polycystic kidney. A case report. Med Ultrason. 2023:1–3. Online ahead of print. doi: 10.11152/mu-3889.
   PubMedGoogle Scholar
• Vogelzang JL, van Stralen KJ, Noordzij M, et al. Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry. Nephrol Dial Transplant. 2015;30(6):1028–1037. doi: 10.1093/ndt/gfv007.
   PubMed Web of Science ®Google Scholar
• Coppolino G, Bolignano D, Rivoli L, et al. Tumour markers and kidney function: a systematic review. Biomed Res Int. 2014;2014:647541. doi: 10.1155/2014/647541.
   PubMed Web of Science ®Google Scholar
• Rosner MH. Cancer screening in patients undergoing maintenance dialysis: who, what, and when. Am J Kidney Dis. 2020;76(4):558–566. doi: 10.1053/j.ajkd.2019.12.018.
   PubMed Web of Science ®Google Scholar